If it feels like the ground has shifted under home health and hospice agencies in the last six months, that's not just a feeling. On May 13, 2026, CMS announced a nationwide, six-month moratorium on new Medicare enrollments for hospices and home health agencies, paired with a public commitment to intensify investigations and expand the use of data analytics across the industry. For agencies already doing the work in good faith, that's created a real and reasonable source of anxiety, because a lot of this enforcement doesn't distinguish cleanly between fraud and an honest documentation gap until well after the scrutiny has already started.

Here's what actually changed, and what it means for agencies who aren't the ones CMS is trying to catch.

What actually changed

The moratorium itself only pauses new enrollments and certain ownership changes, so existing, already-enrolled agencies can keep operating and billing without interruption. But existing providers should still expect a real increase in audit activity, including potential pre-payment review, as CMS redirects enforcement resources toward the providers already in the system rather than just the ones trying to get in.

A few specific tools are doing most of the work here. The Provisional Period of Enhanced Oversight subjects newly enrolled hospices and certain ownership changes to prepayment review. Expanded Prepayment Review does something similar for existing hospices. CMS has also expanded a demonstration project allowing pre- and post-claim review of home health claims in several states, and rolled out a public hospice scoring system meant to flag agencies with troubling utilization or compliance patterns. On top of all that, providers in some regions are reporting more Unified Program Integrity Contractor activity and expanded Targeted Probe and Educate reviews.

The uncomfortable part: documentation gaps are getting treated like fraud

Here's the part that should genuinely concern well-run agencies. A recent compliance guide notes that CMS has revoked Medicare billing privileges for providers whose documentation didn't adequately support eligibility, even in cases centered on documentation deficiencies rather than actual intentional fraud. Eligibility and medical necessity now need to be backed by individualized clinical findings and contemporaneous documentation, not generalized certifications or a retrospective explanation written after the fact.

That's the real risk for good agencies right now. The enforcement tools driving this, data analytics, pattern-based monitoring, prepayment review, aren't built to tell the difference between a bad actor and a busy, well-intentioned agency with inconsistent documentation habits. Both look similar from the outside until a person actually reviews the chart, and by that point billing may already be paused.

It gets harder for agencies with multiple locations

If your agency operates more than one branch, there's an added layer here worth understanding. The same compliance guide points out that CMS increasingly evaluates data across an entire organization rather than treating each location independently, so documentation issues that look isolated at one branch can surface as a broader concern once CMS looks at the pattern across your whole enterprise. Consistency across locations isn't just good practice anymore, it's part of what keeps a smaller issue from becoming a bigger one.

What to actually check right now

Start with whether your documentation would hold up to an ADR request today, not after a few days of scrambling to reconstruct it. One recent breakdown of the moratorium frames the core question well: does your documentation consistently demonstrate eligibility and medical necessity, across every claim, over time, not just on the charts you'd choose to show a reviewer.

Look specifically for the kind of [functional-score-versus-diagnosis mismatch that reviewers tend to flag first](insert OASIS and coding mismatch blog URL), since that's exactly the pattern that turns a routine chart into a closer look. And if you operate multiple locations, check whether your documentation practices are actually consistent across all of them, not just strong at your flagship branch.

Why this is a good moment to build in a real second layer of review

None of this means slowing down or second-guessing good clinical work. It means making sure the story your documentation tells matches what actually happened, consistently, with [a clear audit trail behind every decision](insert AI plus certified coders blog URL) so an ADR request becomes a lookup instead of a reconstruction project.

Talk to us about getting ahead of this

We'd like to show you how our QA process is built to catch exactly the kind of documentation gaps CMS is scrutinizing right now, before they ever become a question in an ADR letter.